Results 141 to 150 of about 1,593 (182)

Assessing differential item functioning for the Social Appearance Anxiety Scale: a Scleroderma atient-centred Intervention Network (SPIN) Cohort Study. [PDF]

BMJ Open, 2020
Sommer SJ, Harel D, Kwakkenbos L, Carrier ME, Gholizadeh S, Gottesman K, Leite C, Malcarne VL, Thombs BD, SPIN Investigators.   +9 more
europepmc   +1 more source

Esclerodermia nodular parcialmente controlada com tofacitinibe

Anais Brasileiros de Dermatologia (Versão em Português)
Kai‐Yi Zhou, Q. Ye, Sheng Fang
semanticscholar   +1 more source

Uso de rituximab en esclerodermia panesclerosante en la infancia: reporte de caso

Alergia, Asma e Inmunología Pediátricas
Adolfo Martín Díaz, Verónica Meléndez, C. López, Dilcia Sauceda-Acosta, Dina Raquel Álvarez-C, Rebecca Paredes-Bonilla   +5 more
semanticscholar   +1 more source

Implantation of autologous fat globules in localized scleroderma and idiopathic lipoatrophy--report of five patients. [PDF]

An Bras Dermatol, 2013
Zanelato TP, Marquesini G, Colpas PT, Magalhães RF, Moraes AM.   +4 more
europepmc   +1 more source

[Bone dysplasias: a presentaion of a family history]. [PDF]

Aten Primaria, 2011
García Ruiz-Rozas J, Orenga Lozano ME, Mayol Jiménez P.   +2 more
europepmc   +1 more source

Hand dysfunction in scleroderma patients. [PDF]

Sao Paulo Med J, 2011
Skare TL, Toebe BL, Boros C.
europepmc   +1 more source

Use of prenatal care and hospital structure according to obstetric risk in Rio de Janeiro, Brazil. [PDF]

Rev Saude Publica
Bittencourt SDA, Domingues RMSM, Ferreira DP, Esteves-Pereira AP, Dias MAB, Nakamura-Pereira M, Bernardo ADN, Blengini PCDGSS, Gomes MASM, Leal MDC.   +9 more
europepmc   +1 more source

Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort. [PDF]

BMJ Open, 2019
Harel D, Mills SD, Kwakkenbos L, Carrier ME, Nielsen K, Portales A, Bartlett SJ, Malcarne VL, Thombs BD, SPIN Investigators.   +9 more
europepmc   +1 more source

[Cancer prevention recommendations: Update 2024]. [PDF]

Aten Primaria
Bartolomé-Moreno C, Melús-Palazón E, Vela-Vallespín C, Arana-Ballestar S, Gallego M, Navarro J, Bellas-Beceiro B, Grupos de expertos del PAPPS.   +7 more
europepmc   +1 more source